Cargando…

Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autores principales: Raghu, Ganesh, Mouded, Majd, Prasse, Antje, Stebbins, Christopher, Zhao, Guolin, Song, Guochen, Arefayene, Million, Violette, Shelia M., Gallagher, Diana, Gibson, Kevin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704833/
https://www.ncbi.nlm.nih.gov/pubmed/35830489
http://dx.doi.org/10.1164/rccm.202205-0868LE
_version_ 1784840142917206016
author Raghu, Ganesh
Mouded, Majd
Prasse, Antje
Stebbins, Christopher
Zhao, Guolin
Song, Guochen
Arefayene, Million
Violette, Shelia M.
Gallagher, Diana
Gibson, Kevin F.
author_facet Raghu, Ganesh
Mouded, Majd
Prasse, Antje
Stebbins, Christopher
Zhao, Guolin
Song, Guochen
Arefayene, Million
Violette, Shelia M.
Gallagher, Diana
Gibson, Kevin F.
author_sort Raghu, Ganesh
collection PubMed
description
format Online
Article
Text
id pubmed-9704833
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-97048332022-11-29 Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis Raghu, Ganesh Mouded, Majd Prasse, Antje Stebbins, Christopher Zhao, Guolin Song, Guochen Arefayene, Million Violette, Shelia M. Gallagher, Diana Gibson, Kevin F. Am J Respir Crit Care Med Correspondence American Thoracic Society 2022-07-13 /pmc/articles/PMC9704833/ /pubmed/35830489 http://dx.doi.org/10.1164/rccm.202205-0868LE Text en Copyright © 2022 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . For commercial usage and reprints, please e-mail Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Raghu, Ganesh
Mouded, Majd
Prasse, Antje
Stebbins, Christopher
Zhao, Guolin
Song, Guochen
Arefayene, Million
Violette, Shelia M.
Gallagher, Diana
Gibson, Kevin F.
Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title_full Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title_fullStr Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title_full_unstemmed Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title_short Randomized Phase IIa Clinical Study of an Anti-α(v)β(6) Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
title_sort randomized phase iia clinical study of an anti-α(v)β(6) monoclonal antibody in idiopathic pulmonary fibrosis
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704833/
https://www.ncbi.nlm.nih.gov/pubmed/35830489
http://dx.doi.org/10.1164/rccm.202205-0868LE
work_keys_str_mv AT raghuganesh randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT moudedmajd randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT prasseantje randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT stebbinschristopher randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT zhaoguolin randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT songguochen randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT arefayenemillion randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT violettesheliam randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT gallagherdiana randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis
AT gibsonkevinf randomizedphaseiiaclinicalstudyofanantiavb6monoclonalantibodyinidiopathicpulmonaryfibrosis